Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells
In 2013, the first case of human infection with an avian influenza A virus (H7N9) was reported in China, and the human infection with this virus has continued as of 2016. At the request of the WHO, we have successfully developed candidate reassortant vaccine virus using A/Anhui/1/2013 and the high e...
Main Authors: | Suzuki, Yasushi, Odagiri, Takato, Tashiro, Masato, Nobusawa, Eri |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959774/ |
Similar Items
-
Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan
by: Ainai, Akira, et al.
Published: (2015) -
Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014
by: Takayama, Ikuyo, et al.
Published: (2016) -
Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
by: Ainai, Akira, et al.
Published: (2013) -
High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7
by: Hamamoto, Itsuki, et al.
Published: (2013) -
Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses
by: Shcherbik, Svetlana, et al.
Published: (2015)